What is NDC 55111-155?

55111-155 is the product NDC for ondansetron hydrochloride, Ondansetron hydrochloride 16 mg/1 tablet, film coated, listed with the FDA by Dr. Reddy's Laboratories Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.

Dr. Reddy's Laboratories Limited, NDC labeler code 55111. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for ondansetron hydrochloride?

78 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

ondansetron hydrochloride NDC 55111-155

NDC codes

FDA NDC Directory

Product NDC (as listed)55111-155Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55111-0155Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
55111-155-05	5511101550555111015505	500 TABLET, FILM COATED in 1 BOTTLE (55111-155-05)Marketed from Dec 26, 2006
55111-155-30	5511101553055111015530	30 TABLET, FILM COATED in 1 BOTTLE (55111-155-30)Marketed from Dec 26, 2006
55111-155-78	5511101557855111015578	10 BLISTER PACK in 1 CARTON (55111-155-78) / 10 TABLET, FILM COATED in 1 BLISTER PACK (55111-155-79)Marketed from Dec 26, 2006

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): ondansetron hydrochloride
Generic name (nonproprietary): ondansetron hydrochloride
Active ingredients: Ondansetron hydrochloride — 16 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Dr. Reddy's Laboratories LimitedNDC labeler code 55111
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076183
Marketing start: Dec 26, 2006
Listing expires: Dec 31, 2027
Other FDA classes: Serotonin 3 Receptor Antagonists (Mechanism)
Identifiers: Product ID 55111-155_9064dccd-0ae4-688a-3216-6ced5e514340SPL ID 9064dccd-0ae4-688a-3216-6ced5e514340SPL set ID 476e704c-95ae-4591-94f7-ee4ab827ff13RxCUI 692695UNII NMH84OZK2B
Pharmacologic class: Serotonin-3 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455111015505 followed by a unit qualifier and the quantity

Package 55111-0155-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 25, 2021.

Indications (excerpt from the label)

Ondansetron tablets are indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 . initial and repeat courses of moderately emetogenic cancer chemotherapy. radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen Ondansetron tablets are also indicated for the prevention of postoperative nausea and/or vomiting. Ondansetron tablets are 5-HT 3 receptor antagonist indicated for the prevention of: nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin greater than or eq…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 55111-155

What is NDC 55111-155?: 55111-155 is the product NDC for ondansetron hydrochloride, Ondansetron hydrochloride 16 mg/1 tablet, film coated, listed with the FDA by Dr. Reddy's Laboratories Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: ondansetron hydrochloride.
What is the active ingredient?: Ondansetron hydrochloride.
Who is the labeler?: Dr. Reddy's Laboratories Limited, NDC labeler code 55111. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for ondansetron hydrochloride?: 78 other product NDCs are listed under this name. See all ondansetron hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other ondansetron hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
ondansetron hydrochloride	Ondansetron hydrochloride 4 mg/1	Tablet, Film coatedOral	Ipca Laboratories Limited	83980-017	83980-0017-1083980-0017-1383980-0017-97
ondansetron hydrochloride	Ondansetron hydrochloride 8 mg/1	Tablet, Film coatedOral	Ipca Laboratories Limited	83980-018	83980-0018-1083980-0018-1383980-0018-97
Ondansetron Hydrochloride	Ondansetron hydrochloride 4 mg/1	Tablet, Film coatedOral	St. Mary's Medical Park Pharmacy	60760-878	60760-0878-10
Ondansetron Hydrochloride	Ondansetron hydrochloride 4 mg/1	Tablet, Film coatedOral	Unit Dose Solutions, Inc.	87441-088	87441-0088-01
Ondansetron Hydrochloride	Ondansetron hydrochloride 4 mg/1	Tablet, Film coatedOral	Unit Dose Solutions, Inc.	87441-064	87441-0064-01
Ondansetron Hydrochloride	Ondansetron hydrochloride 8 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-1242	67046-1242-03
Ondansetron Hydrochloride	Ondansetron hydrochloride 4 mg/1	Tablet, Film coatedOral	Quality Care Products, LLC	83008-074	83008-0074-2083008-0074-30
Ondansetron Hydrochloride	Ondansetron hydrochloride 4 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4145	70518-4145-0070518-4145-0170518-4145-02+3 more
Ondansetron Hydrochloride	Ondansetron hydrochloride 4 mg/1	Tablet, Film coatedOral	Preferred Pharmaceuticals Inc.	68788-8651	68788-8651-0168788-8651-0268788-8651-03+2 more
Ondansetron Hydrochloride	Ondansetron hydrochloride 8 mg/1	Tablet, Film coatedOral	Preferred Pharmaceuticals Inc.	68788-8582	68788-8582-0168788-8582-0268788-8582-03+2 more

All 79 ondansetron hydrochloride NDCs

Other NDCs under ANDA 076183

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 076183
Product	Strength	Form · route	Labeler	Product NDC
Ondansetron	Ondansetron hydrochloride 4 mg/1	Tablet, Film coatedOral	HF Acquisition Co LLC, DBA HealthFirst	51662-1678
ondansetronondansetron hydrochloride	Ondansetron hydrochloride 8 mg/1	Tablet, Film coatedOral	Cardinal Health 107, LLC	55154-7879
ondansetronondansetron hydrochloride	Ondansetron hydrochloride 4 mg/1	Tablet, Film coatedOral	Cardinal Health 107, LLC	55154-3551
Ondansetron	Ondansetron hydrochloride 4 mg/1	Tablet, Film coatedOral	HF Acquisition Co LLC, DBA HealthFirst	51662-1539
Ondansetronondansetron hydrochloride	Ondansetron hydrochloride 8 mg/1	Tablet, Film coatedOral	Dr. Reddy's Laboratories Limited	55111-154
Ondansetronondansetron hydrochloride	Ondansetron hydrochloride 4 mg/1	Tablet, Film coatedOral	Dr. Reddy's Laboratories Limited	55111-153
Ondansetronondansetron hydrochloride	Ondansetron hydrochloride 24 mg/1	Tablet, Film coatedOral	Dr. Reddy's Laboratories Limited	55111-156
ondansetronondansetron hydrochloride	Ondansetron hydrochloride 4 mg/1	Tablet, Film coatedOral	Major Pharmaceuticals	0904-6551
ondansetronondansetron hydrochloride	Ondansetron hydrochloride 8 mg/1	Tablet, Film coatedOral	Major Pharmaceuticals	0904-6552
ondansetron hydrochloride	Ondansetron hydrochloride 4 mg/1	Tablet, Film coatedOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8185